Invest II Scsp Droia - 17 Jun 2021 Form 3 Insider Report for Cyteir Therapeutics, Inc.

Role: 10%+ Owner
Signature: Droia Invest II SCSp, By: DF II GP Sarl, By: /s/ Janwillem Naesens, Name: Wepaven BV (represented by Janwillem Naesens), Title: Manager
Issuer symbol: N/A
Transactions as of: 17 Jun 2021
Net transactions value: $0
Form type: 3
Filing time: 17 Jun 2021, 21:44:57 UTC
Next filing: 24 Jun 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CYT	Series B Convertible Preferred Stock							17 Jun 2021	Common Stock	2,933,583		Direct	F1, F2
holding	CYT	Series C Convertible Preferred Stock							17 Jun 2021	Common Stock	325,442		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, the "Preferred Stock") are convertible into the number of shares of the Issuer's common stock shown in column 3 and have no expiration date. The Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
F2	Shares held by Droia Invest II SCSp. DF II GP Sarl is the general partner of Droia Invest II SCSp. Wepaven BV (represented by Janwillem Naesens) and IHL SA (represented by Luc Verelst), the managers of DF II GP Sarl, share voting and investment power with respect to the shares held of record by Droia Invest II SCSp. Mr. Naesens, a member of the Issuer's board of directors, disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. Luc Verelst disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.

Content

The Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, the "Preferred Stock") are convertible into the number of shares of the Issuer's common stock shown in column 3 and have no expiration date. The Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.

Shares held by Droia Invest II SCSp. DF II GP Sarl is the general partner of Droia Invest II SCSp. Wepaven BV (represented by Janwillem Naesens) and IHL SA (represented by Luc Verelst), the managers of DF II GP Sarl, share voting and investment power with respect to the shares held of record by Droia Invest II SCSp. Mr. Naesens, a member of the Issuer's board of directors, disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. Luc Verelst disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.